CVS Health Co. (NYSE:CVS) Shares Sold by Meyer Handelman Co.

Meyer Handelman Co. decreased its stake in shares of CVS Health Co. (NYSE:CVS - Free Report) by 7.5% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 112,811 shares of the pharmacy operator's stock after selling 9,103 shares during the period. Meyer Handelman Co.'s holdings in CVS Health were worth $5,064,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of CVS. MidAtlantic Capital Management Inc. purchased a new stake in CVS Health during the third quarter valued at about $25,000. Ridgewood Investments LLC increased its position in CVS Health by 255.7% during the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator's stock worth $28,000 after purchasing an additional 450 shares in the last quarter. Livelsberger Financial Advisory purchased a new position in CVS Health in the third quarter valued at approximately $31,000. Legacy Investment Solutions LLC acquired a new position in CVS Health during the third quarter valued at approximately $31,000. Finally, Reston Wealth Management LLC purchased a new stake in CVS Health during the third quarter worth approximately $32,000. Hedge funds and other institutional investors own 80.66% of the company's stock.

Wall Street Analysts Forecast Growth

CVS has been the topic of several recent research reports. Wells Fargo & Company upgraded shares of CVS Health from an "equal weight" rating to an "overweight" rating and lifted their target price for the company from $60.00 to $66.00 in a report on Monday, November 18th. Royal Bank of Canada decreased their target price on CVS Health from $68.00 to $58.00 and set an "outperform" rating for the company in a research report on Friday, November 15th. Truist Financial dropped their target price on CVS Health from $67.00 to $60.00 and set a "buy" rating on the stock in a report on Monday, January 6th. UBS Group upped their price target on CVS Health from $60.00 to $62.00 and gave the stock a "neutral" rating in a report on Thursday, November 7th. Finally, TD Cowen lifted their price objective on shares of CVS Health from $73.00 to $80.00 and gave the company a "buy" rating in a research note on Monday, November 25th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $68.71.

CVS Health Stock Performance

NYSE:CVS traded up $0.58 during trading hours on Wednesday, reaching $52.15. 8,471,259 shares of the stock were exchanged, compared to its average volume of 14,413,939. CVS Health Co. has a 52 week low of $43.56 and a 52 week high of $80.75. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The stock has a market capitalization of $65.63 billion, a P/E ratio of 13.24, a P/E/G ratio of 0.85 and a beta of 0.59. The firm has a 50 day simple moving average of $51.68 and a 200-day simple moving average of $56.44.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping analysts' consensus estimates of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. During the same quarter in the previous year, the company posted $2.21 earnings per share. The firm's revenue was up 6.3% on a year-over-year basis. As a group, sell-side analysts forecast that CVS Health Co. will post 5.32 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 5.10%. The ex-dividend date is Thursday, January 23rd. CVS Health's payout ratio is 67.51%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.